Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Sarah Al-Obaydi, Paddy Ssentongo, John J Cherneskie, Timothy J Craig, Taha Al-Shaikhly
No abstract text is available yet for this article.
September 29, 2023: Annals of Allergy, Asthma & Immunology
#2
JOURNAL ARTICLE
Cecchi Lorenzo, Poncet Pascal, Maltagliati Lucia, Carli Giulia, Macchia Donatella, Maggi Laura, Meucci Elisa, Parronchi Paola, Mazzoni Alessio, Salvati Lorenzo, Scala Enrico, Sénéchal Hélène, Aizawa Tomoyasu, Villalta Danilo, Annunziato Francesco, Cosmi Lorenzo, Farsi Alessandro
BACKGROUND: Pru p 7 was the first gibberellin-regulated protein (GRP) to be identified as a food allergen at the basis of a pollen food allergy syndrome. OBJECTIVE: The study aimed to clinically and biologically characterize a group of patients with suspected allergy to Pru p 7 in order to optimize the diagnostic work-up of GRP sensitization. METHODS: Allergy to Pru p 7 was suspected in the presence of a systemic allergic reaction to plant food, positive skin prick tests for cypress pollen and LTP-enriched peach extract, and absence of Pru p 3-specific IgE...
September 25, 2023: Annals of Allergy, Asthma & Immunology
#3
REVIEW
Nicholas Stefanovic, Alan D Irvine
Atopic dermatitis is the most common inflammatory skin disease worldwide, affecting 20% of children and 5% of adults. One critical component in the pathophysiology of atopic dermatitis is the epidermal skin barrier, with its outermost layer- the stratum corneum (SC) being conferring biochemical properties that enable resilience against environmental threats and maintain homeostasis. The skin barrier may be conceptualized as a key facilitator of complex interactions between genetics, host immunity, the cutaneous microbiome, and environmental exposures...
September 25, 2023: Annals of Allergy, Asthma & Immunology
#4
REVIEW
Aikaterini Anagnostou
OBJECTIVE: Shared decision-making is increasingly used in food allergy. We review its use in the areas of prevention, diagnosis and management. DATA SOURCES: PubMed and online shared decision-making resources. STUDY SELECTIONS: Studies and reviews relevant to shared decision-making and areas in food allergy that decision-making may be applied, were selected for discussion. RESULTS: Food allergy represents an area with multiple opportunities for SDM...
September 22, 2023: Annals of Allergy, Asthma & Immunology
#5
EDITORIAL
Grace Oscullo, Jose Daniel Gomez-Olivas, Miguel Ángel Martínez-García
No abstract text is available yet for this article.
September 21, 2023: Annals of Allergy, Asthma & Immunology
#6
JOURNAL ARTICLE
Michael Blaiss, John Oppenheimer, Mark Corbett, Len Bacharier, Jonathan Bernstein, Tara Carr, Bradley Chipps, Simon Couillard, Erick Forno, Torie Grant, Njira Lugogo, Kathleen May, Eric Schauberger
No abstract text is available yet for this article.
September 8, 2023: Annals of Allergy, Asthma & Immunology
#7
JOURNAL ARTICLE
Mitchell H Grayson, Paul V Williams
No abstract text is available yet for this article.
September 7, 2023: Annals of Allergy, Asthma & Immunology
#8
JOURNAL ARTICLE
Kristin M Hunt, Mary Foley, Lori A Connors, Kyla J Hildebrand, Anne K Ellis
BACKGROUND: Women in medicine continue to be underrepresented at medical conferences. Previous studies have examined the proportion of invited female speakers across multiple specialties and evaluated factors that may have led to this disparity. The field of allergy and immunology has often been excluded and analyses have not demonstrated how the trends have changed over the last decade. OBJECTIVE: To examine the distribution of invited speakers by gender over time at the three largest North American allergy and immunology conferences...
September 7, 2023: Annals of Allergy, Asthma & Immunology
#9
JOURNAL ARTICLE
Luca Delli Colli, Adnan Al Ali, Sofianne Gabrielli, Marina Delli Colli, Pasquale Mule, Benjamin Lawson, Ann E Clarke, Judy Morris, Jocelyn Gravel, Rod Lim, Edmond S Chan, Ran D Goldman, Andrew O'Keefe, Jennifer Gerdts, Derek K Chu, Julia Upton, Elana Hochstadter, Adam Bretholz, Christine McCusker, Xun Zhang, Shira Benor, Elinor Simons, Elissa M Abrams, Jennifer L P Protudjer, Moshe Ben-Shoshan
BACKGROUND: Epinephrine is the first-line treatment for anaphylaxis but is often replaced with antihistamines or corticosteroids. Delayed epinephrine administration is a risk factor for fatal anaphylaxis. Convincing data on the role of antihistamines and corticosteroids in anaphylaxis management is sparse. OBJECTIVE: To establish the impact of prehospital treatment with epinephrine, antihistamines, and/or corticosteroids in anaphylaxis management. METHODS: Patients presenting with anaphylaxis were recruited prospectively and retrospectively in 10 Canadian and one Israeli emergency departments (ED) between April 2011 and August 2022, as part of the Cross-Canada Anaphylaxis Registry...
September 7, 2023: Annals of Allergy, Asthma & Immunology
#10
REVIEW
Hana Seastedt, Kari Nadeau
Increased use of fossil fuels has led to global warming with concomitant increases in the severity and frequency of extreme weather events such as wildfires and sand and dust storms. These changes have led to increases in air pollutants such as particulate matter and greenhouse gases. Global warming is also associated with increases in pollen season length and pollen concentration. Particulate matter, greenhouse gases, and pollen synergistically increase incidence and severity of allergic diseases. Other indirect factors such as droughts, flooding, thunderstorms, heat waves, water pollution, human migration, deforestation, loss of green space, and decreasing biodiversity (including microbial diversity) also affect incidence and severity of allergic disease...
September 7, 2023: Annals of Allergy, Asthma & Immunology
#11
JOURNAL ARTICLE
Rasads Misirovs, Rory Chan, Brian Lipworth
No abstract text is available yet for this article.
September 7, 2023: Annals of Allergy, Asthma & Immunology
#12
JOURNAL ARTICLE
George N Konstantinou, Mary Grace Baker, Joyce Yu, Lara S Ford, Ramon Bencharitiwong, Galina Grishina, Hugh Sampson, Scott Sicherer, Anna Nowak-Wegrzyn
BACKGROUND: Patients exquisitely sensitive to cashew/pistachio are at risk for allergic reactions to citrus seeds and pectin. OBJECTIVE: In this study, we sought to examine whether pectin is contaminated with citrus seeds, to identify a culprit antigen in citrus seeds, and to assess for cross-reactivity among allergens in citrus seeds, citrus pectin, and cashew/pistachio. METHODS: Proteins from orange seed coats, orange seed endosperms, lemon seeds, grapefruit seeds, citrus pectin, apple pectin, and grapefruit pectin were extracted...
August 31, 2023: Annals of Allergy, Asthma & Immunology
#13
JOURNAL ARTICLE
Stanley M Fineman, Sarah Spriet, Iris Otani, Gerald B Lee
No abstract text is available yet for this article.
August 31, 2023: Annals of Allergy, Asthma & Immunology
#14
JOURNAL ARTICLE
Sebastian Ferri, Carlo Montagna, Marta Casini, Luca Malvezzi, Francesca Pirola, Elena Russo, Francesca Racca, Maria Rita Messina, Francesca Puggioni, Emanuele Nappi, Giovanni Costanzo, Lorenzo Del Moro, Giuseppe Mercante, Giuseppe Spriano, Giorgio Walter Canonica, Giovanni Paoletti, Enrico Heffler
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant burden on patients' quality of life and impaired sleep quality. The most common CRSwNP endotype is characterized by type-2 inflammation, with enhanced production of interleukin (IL)-4, IL-5 and IL-13. Dupilumab is a monoclonal antibody against IL-4 receptor-alpha, which inhibits both IL-4 and IL-13 signaling, and was recently approved for treatment of CRSwNP. OBJECTIVE: We investigated the effect of Dupilumab on sleep quality in patients with CRSwNP in a real-life setting...
August 29, 2023: Annals of Allergy, Asthma & Immunology
#15
JOURNAL ARTICLE
Ayel Luis R Batac, Kaitlyn A Merrill, Michael A Golding, Elissa M Abrams, Philippe Bégin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E Roos, Vladan Protudjer, Jennifer L P Protudjer
No abstract text is available yet for this article.
August 29, 2023: Annals of Allergy, Asthma & Immunology
#16
JOURNAL ARTICLE
Marcus S Shaker, Elissa M Abrams, Douglas P Mack, Edmond S Chan, Edward G A Iglesia, David B K Golden, Matthew Greenhawt
No abstract text is available yet for this article.
August 29, 2023: Annals of Allergy, Asthma & Immunology
#17
REVIEW
Ianthe R M Schepel, Tina M Banzon, Wanda Phipatanakul
OBJECTIVE: To evaluate the current evidence, its limitations, and future research directions for the use of biologics in pediatric asthma, with a particular focus on the potential use of biologics to prevent pediatric asthma and equity issues in access to biologic treatment and research participation. DATA SOURCES: PubMed articles about the use of biologics in pediatric asthma were searched up to May 2023. STUDY SELECTIONS: Recent (2019-2023) original research articles and reviews were prioritized...
August 29, 2023: Annals of Allergy, Asthma & Immunology
#18
JOURNAL ARTICLE
Sarah Zhang, Peck Y Ong
No abstract text is available yet for this article.
August 28, 2023: Annals of Allergy, Asthma & Immunology
#19
JOURNAL ARTICLE
Purnadeo N Persaud, Annie P Tran, Donna Messner, J Daryl Thornton, Dennis Williams, Logan J Harper, Vickram Tejwani
BACKGROUND: A multistakeholder core outcome set created for asthma trials showed that asthma specific quality of life (QoL) was a critically meaningful outcome. However, the definition and how to measure it was undetermined. The adverse effects (AEs) of corticosteroids may be a vital clinical trial outcome. Yet, the AE burden from the patient perspective has not yet been elucidated in an asthma population. OBJECTIVE: To characterize patient burden of AEs in oral (OCS) and inhaled corticosteroids (ICS) and how this relates to QoL within an asthma population...
August 27, 2023: Annals of Allergy, Asthma & Immunology
#20
JOURNAL ARTICLE
Ghislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, Trung N Tran, Ruth Murray, Neil Martin, Andrew N Menzies-Gow, Mark Hew, Matthew J Peters, Peter G Gibson, George C Christoff, Todor A Popov, Andréanne Côté, Celine Bergeron, Delbert Dorscheid, J Mark FitzGerald, Kenneth R Chapman, Louis Philippe Boulet, Mohit Bhutani, Mohsen Sadatsafavi, Libardo Jiménez-Maldonado, Mauricio Duran-Silva, Bellanid Rodriguez, Carlos Andres Celis-Preciado, Diana Jimena Cano-Rosales, Ivan Solarte, Maria Jose Fernandez-Sanchez, Patricia Parada-Tovar, Anna von Bülow, Anne Sofie Bjerrum, Charlotte S Ulrik, Karin Dahl Assing, Linda Makowska Rasmussen, Susanne Hansen, Alan Altraja, Arnaud Bourdin, Camille Taille, Jeremy Charriot, Nicolas Roche, Andriana I Papaioannou, Konstantinos Kostikas, Nikolaos G Papadopoulos, Sundeep Salvi, Deirdre Long, Patrick D Mitchell, Richard Costello, Concetta Sirena, Cristina Cardini, Enrico Heffler, Francesca Puggioni, Giorgio Walter Canonica, Giuseppe Guida, Takashi Iwanaga, Mona Al-Ahmad, Désirée Larenas Linnemann, Ulises García, Piotr Kuna, João A Fonseca, Riyad Al-Lehebi, Mariko Koh Siyue, Chin Kook Rhee, Borja G Cosio, Luis Perez de Llano, Diahn-Warng Perng Steve, Erick Wan-Chun Huang, Hao-Chien Wang, Ming-Ju Tsai, Bassam Mahboub, Laila Ibraheem Jaber Salameh, David Jackson, John Busby, Liam G Heaney, Paul Pfeffer, Amanda Grippen Goddard, Eileen Wang, Flavia Hoyte, Michael E Wechsler, Nicholas Chapman, Rohit Katial, Victoria Carter, Lakmini Bulathsinhala, Neva Eleangovan, Con Ariti, Juntao Lyu, David Price, Celeste Porsbjerg
BACKGROUND: Investigation for the presence of asthma comorbidities is recommended by GINA as their presence can complicate asthma management. OBJECTIVE: To understand the prevalence and pattern of comorbidities and multimorbidity in adults with severe asthma and their association with asthma-related outcomes. METHODS: This was a cross-sectional study using data from the International Severe Asthma Registry from 22 countries. Thirty comorbidities were identified and categorized a priori as either (1) potentially T2-related, (2) potentially oral corticosteroid (OCS)-related or (3) mimicking/aggravating asthma...
August 26, 2023: Annals of Allergy, Asthma & Immunology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
